We install and test the CSF charge coolers on our F10 M5 and F13 M6 to see the performance gains. Cooler temps mean more ...

A collaborative research team has developed the world's first AI-based optical diagnostic platform that enables rapid and ...

A new finger prick test claims to detect Alzheimer’s with 91% accuracy using p-tau217 biomarkers. Learn how this accessible ...

Is it three steps forward, one step back for blood tests? At the 18th Clinical Trials on Alzheimer’s Disease, held December 1–4 in San Diego, new data on the FDA-approved Fujirebio Lumipulse plasma ...

NEW YORK – Breast cancer researchers at the Dana-Farber Cancer Institute and Harvard Cancer Center are investigating whether a CSF-1R inhibitor can overcome PARP inhibitor resistance associated with ...

Carole Rainey, whose name has been changed to protect her privacy, started to notice something wasn’t quite right with her husband, Bill, when he began to ramble in a way that was unlike him. He had ...

SECAUCUS, N.J., Oct. 27, 2025 /PRNewswire/ -- Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in symptomatic patients, supporting ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI scans may reveal a suspicious-looking lesion, but the only sure way to ...

A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers ...